Low risk of relapse in aplastic anemia patients after SARS-CoV-2 omicron infection: A prospective NICHE cohort

Am J Hematol. 2023 Oct;98(10):E272-E275. doi: 10.1002/ajh.27028. Epub 2023 Jul 14.

Authors

Lele Zhang^{1

2}, Jingyu Zhao^{1

2}, Ruonan Li^{1

2}, Hong Pan^{1

2}, Zhen Gao^{1

2}, Weiwang Li^{1

2}, Liwei Fang^{1

2}, Jun Shi^{1

2}

Affiliations

¹ Regenerative Medicine Clinic, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
² Tianjin Institutes of Health Science, Tianjin, China.

PMID: 37449449
DOI: 10.1002/ajh.27028

No abstract available

Publication types

Letter

MeSH terms

Anemia, Aplastic* / therapy
COVID-19* / complications
Chronic Disease
Humans
Prospective Studies
Recurrence
SARS-CoV-2